Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Eduardo Richardet"'
Autor:
Enriqueta Felip, David P. Carbone, Martin Reck, Luis Paz-Ares, Yong Yuan, Nan Hu, Niels Reinmuth, Xiaoqing Zhang, Thomas John, Ying Cheng, Shun Lu, Manuel Cobo, Michael Schenker, Tudor-Eliade Ciuleanu, Stéphanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Eduardo Richardet, Hideaki Mizutani, Bogdan Zurawski, Aurelia Alexandru, Javed Mahmood, Tuli De, Irene Santi, John R. Penrod, Adam Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background In CheckMate 9LA, nivolumab plus ipilimumab with chemotherapy prolonged overall survival (OS) versus chemotherapy regardless of tumor PD-L1 expression or histology. We report updated efficacy and safety in all randomized patients with a mi
Externí odkaz:
https://doaj.org/article/c372aee3045841d7bf925f1ae98c8480
Autor:
Khalid El Bairi, Harry R. Haynes, Elizabeth Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Fujimoto, Luz F. Sua, Shi-Wei Liu, Huang-Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I-Chun Chen, Veronica Bautista, Jose Fernando Do Prado Moura, Bernardo L. Rapoport, Carlos Castaneda, Eunice Spengler, Gabriela Acosta-Haab, Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard-Gallo, An Coosemans, Edith A. Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M. S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, William Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernan Garcia-Rivello, Hugo Horlings, Said Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-17 (2021)
Abstract The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of pr
Externí odkaz:
https://doaj.org/article/98d18f7227c34bcb8909cccb39302c30
Autor:
Carolina Bernabe-Ramirez, Ana I. Velazquez, Coral Olazagasti, Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Jose Corona Cruz, Ivy Riano, Christina Adaniel, Francisca Ramirez, Jesus Anampa, Carmen Cajina, Evelin Mena, Elias Gracia, Alvaro Menendez, Henry Idrovo, Raimundo Bezares, Omar Orlando Castillo Fernandez, Liseth Duque, Luis Corrales-Rodríguez, Glenda Ramos, Alba J. Kihn-Alarcón, Ilana Schlam, Ximena Bruno, Gerardo Umanzor, Jenny Lissette Castro, Federico Losco, Luis Ubillos, Eduardo Richardet, Enrique Soto-Perez-de-Celis, Narjust Duma
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEThe HOLA COVID-19 study sought to evaluate the impact of COVID-19 on oncology practices across Latin America (LATAM), challenges faced by physicians, and how practices and physicians adapted while delivering care to patients with cancer.METHOD
Externí odkaz:
https://doaj.org/article/4f8fbca8167d48e68fa0bda9b7f6f357
Autor:
Martin Reck, Tudor-Eliade Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Zurawski, Juliana Menezes, Eduardo Richardet, Jaafar Bennouna, Enriqueta Felip, Oscar Juan-Vidal, Aurelia Alexandru, Ying Cheng, Hiroshi Sakai, Luis Paz-Ares, Shun Lu, Thomas John, Xiaowu Sun, Aniela Moisei, Fiona Taylor, Rachael Lawrance, Xiaoqing Zhang, Judi Sylvester, Yong Yuan, Steven I. Blum, John R. Penrod, David P. Carbone
Publikováno v:
European Journal of Cancer. 183:174-187
Autor:
Luis G. Paz-Ares, Tudor-Eliade Ciuleanu, Manuel Cobo, Jaafar Bennouna, Michael Schenker, Ying Cheng, Oscar Juan-Vidal, Hideaki Mizutani, Alejo Lingua, Felipe Reyes-Cosmelli, Niels Reinmuth, Juliana Menezes, Jacek Jassem, Svetlana Protsenko, Eduardo Richardet, Enriqueta Felip, Kynan Feeney, Bogdan Zurawski, Aurelia Alexandru, Emmanuel de la Mora Jimenez, Shaker Dakhil, Shun Lu, Martin Reck, Thomas John, Nan Hu, Xiaoqing Zhang, Judi Sylvester, Laura J. Eccles, Diederik J. Grootendorst, David Balli, Jaclyn Neely, David P. Carbone
Publikováno v:
Scientia
Non–small cell lung cancer; Brain metastases; Somatic mutations Càncer de pulmó de cèl·lules no petites; Metàstasis cerebrals; Mutacions somàtiques Cáncer de pulmón de células no pequeñas; Metástasis cerebrales; Mutaciones somáticas Int
Publikováno v:
Journal of Thoracic Oncology. 18:S12
Autor:
Eduardo Richardet, I. Magi, V. Peruchin, P. Perea, A. Tello, M. Molina, L. Acosta, M. Paradelo, M. Richardet
Publikováno v:
Journal of Thoracic Oncology. 18:S12
Autor:
Eduardo Richardet, I. Magi, V. Peruchin, P. Perea, A. Tello, M. Molina, L. Acosta, M. Paradelo, M. Richardet
Publikováno v:
Journal of Thoracic Oncology. 18:S12
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Toni K. Choueiri, Howard Gurney, David F. McDermott, Christian Kollmannsberger, Michael A. Carducci, Martin Eduardo Richardet, M. Brent McHenry, Elizabeth R. Plimack, Fabio A.B. Schutz, David Cella, Nizar M. Tannir, Frede Donskov, Bernard Escudier, John Wagstaff, Yoshihiko Tomita, Robert J. Motzer, Satoshi Fukasawa, Shruti Shally Saggi, Saby George, Giuseppe Procopio, Christine Chevreau, Hans J. Hammers, Thomas Gauler, Daniel Castellano, Jeffrey A. Sosman, James Larkin, Ajjai Alva, Sandhya Srinivas, Katriina Peltola, Scott S. Tykodi, Stéphane Oudard
Publikováno v:
Cancer
Motzer, R J, Escudier, B, George, S, Hammers, H J, Srinivas, S, Tykodi, S S, Sosman, J A, Plimack, E R, Procopio, G, McDermott, D F, Castellano, D, Choueiri, T K, Donskov, F, Gurney, H, Oudard, S, Richardet, M, Peltola, K, Alva, A S, Carducci, M, Wagstaff, J, Chevreau, C, Fukasawa, S, Tomita, Y, Gauler, T C, Kollmannsberger, C K, Schutz, F A, Larkin, J, Cella, D, McHenry, M B, Saggi, S S & Tannir, N M 2020, ' Nivolumab versus everolimus in patients with advanced renal cell carcinoma : Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial ', Cancer, vol. 126, no. 18, pp. 4156-4167 . https://doi.org/10.1002/cncr.33033
Motzer, R J, Escudier, B, George, S, Hammers, H J, Srinivas, S, Tykodi, S S, Sosman, J A, Plimack, E R, Procopio, G, McDermott, D F, Castellano, D, Choueiri, T K, Donskov, F, Gurney, H, Oudard, S, Richardet, M, Peltola, K, Alva, A S, Carducci, M, Wagstaff, J, Chevreau, C, Fukasawa, S, Tomita, Y, Gauler, T C, Kollmannsberger, C K, Schutz, F A, Larkin, J, Cella, D, McHenry, M B, Saggi, S S & Tannir, N M 2020, ' Nivolumab versus everolimus in patients with advanced renal cell carcinoma : Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial ', Cancer, vol. 126, no. 18, pp. 4156-4167 . https://doi.org/10.1002/cncr.33033
Background: CheckMate 025 has shown superior efficacy for nivolumab over everolimus in patients with advanced renal cell carcinoma (aRCC) along with improved safety and tolerability. This analysis assesses the long-term clinical benefits of nivolumab